Clinical Trials Browser

OTHER_GOV × Thoracic × Clear all

NCT07442890 2026-03-02

A Cohort Study on the Prevention of Nausea and Vomiting Induced by Concurrent Chemoradiotherapy for Lung Cancer Using Rolapitant and Palonosetron

Phase NA Not yet recruiting

Lung Neoplasms

NCT07426718 2026-02-23

VICTORY 2

Not yet recruiting

Disease, Lung Neoplasms, Pneumonia

NCT07192926 2026-02-20

SARCO-CTI

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Neoplasms, Sarcopenia

NCT05875870 2026-02-17

Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With Cancer

Phase NA Recruiting

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms

NCT07400575 2026-02-10

NSCLC SCLC

Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07401498 2026-02-10

LNDNSCLC-RUS

Phase NA Enrolling by invitation

Lymph Node Dissection

NCT07388225 2026-02-05

The Effect of Preoperative Education on Recovery of Thoracic Surgery Patients

Phase NA Completed

Lung Neoplasms

NCT06370416 2026-01-28

the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib

Phase 2 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

NCT07320105 2026-01-06

Postoperative Radiotherapy for Postoperative N2 Metastases of NSCLC in the Immunotherapy Era (Phase II)

Phase 4 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07279402 2025-12-12

TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%

Carcinoma, Non-Small-Cell Lung

NCT07280559 2025-12-12

Evaluation of AI-assisted LDCT Screening in Lung Cancer

Phase NA Not yet recruiting

Lung Neoplasms

NCT07244016 2025-11-24

ES-SCLC

Small Cell Lung Carcinoma

NCT05236946 2025-09-10

Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT

Phase 3 Recruiting

Asymptomatic Brain Metastases

NCT05277844 2025-09-10

TARGET-01

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT05278052 2025-09-10

TARGET-02

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06322329 2025-09-02

RealMove(lung)

Phase NA Recruiting

Lung Neoplasms

NCT07131163 2025-08-20

NoSurgery

Carcinoma, Non-Small-Cell Lung

NCT07108816 2025-08-07

A Single-center, Phase II Clinical Trial Evaluating the Efficacy of Sacituzumab Tirumotecan in Combination With Tagitanlimab as Neoadjuvant Therapy for PD-L1-positive, Resectable Stage II to IIIB Non-small Cell Lung Cancer (NSCLC)

Phase 2 Not yet recruiting

Resectable Stage II-IIIB NSCLC

NCT07107893 2025-08-06

Comparison of Double Lumen Tube Location Verification Techniques in Single Lung Ventilation

Lung Diseases, Lung Neoplasms

NCT06709859 2025-07-17

Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07069270 2025-07-16

A Study on the First-line Treatment of Small Cell Lung Cancer With Adebrelimab and Vunakizumab and Chemotherapy

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT06617936 2025-07-15

Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.

Phase 2 Recruiting

Unresectable Non-small Cell Lung Cancer

NCT06971848 2025-07-11

ETCABIO

Phase NA Not yet recruiting

GastrointestinalLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellThoracic

Immunoglobulin Light-chain Amyloidosis, Esophageal Squamous Cell Carcinoma, Mesothelioma, Malignant, Carcinoma, Bronchogenic, Heart Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Follicular, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Cholangiocarcinoma, Neoplasms, Plasma Cell

NCT06232083 2025-07-09

A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)

Phase 1 Recruiting

GastrointestinalGynecologicThoracic

Uterine Cervical Neoplasms, Esophageal Neoplasms, Lung Neoplasms

NCT07050043 2025-07-03

LEDANG

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT03093688 2025-07-02

Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor

Phase 1/2 Recruiting

GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma

NCT07039994 2025-06-26

AIRPAL

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung

NCT02078700 2025-06-25

Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.

Phase 2 Completed

GastrointestinalOther solid neoplasmThoracic

Lung Neoplasms, Mesothelioma, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT02324296 2025-06-11

PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases

Small Cell Lung Carcinoma

NCT02405273 2025-06-11

PUREAIR

Phase NA Completed

Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

NCT06971406 2025-05-14

FLAME-1

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT06964698 2025-05-09

Optimizing Post-Thoracotomy Pain Management: Comparing Erector Spinae vs. Paravertebral Block in Thoracotomy Patients

Lung Diseases, Lung Neoplasms

NCT06959173 2025-05-06

Organoid-guided Personalized Treatment of Pleural Effusion

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pleural Effusion

NCT06939049 2025-04-22

SISTEMA

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06926803 2025-04-15

A Clinical Study of Furmonertinib in the Treatment of EGFR-Mutated NSCLC With Leptomeningeal Metastases

Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06900283 2025-04-03

FACT-L_Pred

Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06051136 2025-04-02

OVER-CRF

Phase NA Active not recruiting

Lung Neoplasms

NCT06643000 2025-03-06

Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT06854939 2025-03-03

MRDSEEKER

Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm, Residual

NCT06846736 2025-02-26

ALKDigPath

Enrolling by invitation

Alk-positive Non-Small Cell Lung Cancer

NCT06796816 2025-01-28

BIVA-18

Phase NA Recruiting

Adenocarcinoma of Lung, Lung Neoplasms, Sarcopenia

NCT06793228 2025-01-27

Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia

Phase 2 Not yet recruiting

SCLC, Extensive Stage

NCT06786208 2025-01-22

Real-world Study of Sunvozertinib Treatment in Advanced EGFR-Mutant NSCLC After EGFR-TKI Treatment Failure

Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06786312 2025-01-22

A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT06760676 2025-01-07

A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy

Phase 1 Not yet recruiting

GastrointestinalGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms

NCT05212103 2024-12-04

CANSI

Enrolling by invitation

DermatologicOther hematologic neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Leukemia, Myeloid, Acute

NCT06679712 2024-11-07

5ALA-TBPDT

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06249854 2024-10-01

Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06618391 2024-10-01

Local Injection and Systemic Therapy in the Treatment of NSCLC.

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06614621 2024-09-26

A Study of Adebelimab Combined With Chemotherapy as a First-line Treatment Sequential Treatment for Extensive-stage Small Cell Lung Cancer

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma